257 related articles for article (PubMed ID: 11399815)
21. [Serum ferritin in donors with regular plateletpheresis].
Ma CH; Guo RH; Wu WJ; Yan JX; Yu JL; Zhu YH; He QT; Luo YH; Huang L; Ye RY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):508-10. PubMed ID: 21518519
[TBL] [Abstract][Full Text] [Related]
22. Plateletpheresis-associated lymphopenia in frequent platelet donors.
Gansner JM; Rahmani M; Jonsson AH; Fortin BM; Brimah I; Ellis M; Smeland-Wagman R; Li ZJ; Schenkel JM; Brenner MB; Yefidoff-Freedman R; Sloan SR; Berliner N; Issa NC; Baden LR; Longo DL; Wesemann DR; Neuberg D; Rao DA; Kaufman RM
Blood; 2019 Feb; 133(6):605-614. PubMed ID: 30429159
[TBL] [Abstract][Full Text] [Related]
23. Clinical Indications and Adverse Reactions of Platelet Apheresis.
Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
[TBL] [Abstract][Full Text] [Related]
24. The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective.
Hirani R; Peberdy J; Mondy P
Transfus Apher Sci; 2018 Apr; 57(2):239-242. PubMed ID: 29530405
[TBL] [Abstract][Full Text] [Related]
25. Effect of Frequency of Platelet Apheresis on Coagulation Function in Donors: A Prospective Cohort Study.
Feng Q; Zhu F; Li C; Guo B; Ye J; Chen J
Indian J Hematol Blood Transfus; 2019 Oct; 35(4):736-741. PubMed ID: 31741630
[TBL] [Abstract][Full Text] [Related]
26. CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.
Rahmani M; Fortin BM; Berliner N; Issa N; Neuberg D; Kaufman RM; Gansner JM
Transfusion; 2019 May; 59(5):1644-1647. PubMed ID: 30747442
[TBL] [Abstract][Full Text] [Related]
27. Demographic, laboratory, and operational variables that influence short- and long-term plateletpheresis yields.
Badami KG; Sesun M; Basu A; Absalom N
J Clin Apher; 2012 Nov; 27(5):247-54. PubMed ID: 22730096
[TBL] [Abstract][Full Text] [Related]
28. Effect of plateletpheresis on total platelet count and mean platelet volume: A meta-analysis.
Gil-Betancur A; Mantilla-Gutierrez CY; Cardona-Arias JA
J Evid Based Med; 2020 Aug; 13(3):206-214. PubMed ID: 32615026
[TBL] [Abstract][Full Text] [Related]
29. Plateletpheresis donor deferral pattern: A retrospective 4-year data analysis at tertiary care center in India.
Yadav BK; Shrivastava H; Katharia R; Chaudhary RK
Asian J Transfus Sci; 2022; 16(2):214-218. PubMed ID: 36687534
[TBL] [Abstract][Full Text] [Related]
30. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
[TBL] [Abstract][Full Text] [Related]
31. Donor platelet response and product quality assurance in plateletpheresis.
Lasky LC; Lin A; Kahn RA; McCullough J
Transfusion; 1981; 21(3):247-60. PubMed ID: 7233509
[TBL] [Abstract][Full Text] [Related]
32. Donor deferral characteristics for plateletpheresis at a tertiary care center in India- a retrospective analysis.
Pujani M; Jyotsna PL; Bahadur S; Pahuja S; Pathak C; Jain M
J Clin Diagn Res; 2014 Jul; 8(7):FC01-3. PubMed ID: 25177566
[TBL] [Abstract][Full Text] [Related]
33. Generation of reticulated platelets in response to whole blood donation or plateletpheresis.
Gyongyossy-Issa MI; Miranda J; Devine DV
Transfusion; 2001 Oct; 41(10):1234-40. PubMed ID: 11606821
[TBL] [Abstract][Full Text] [Related]
34. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
35. To study the effect of 'Covishield' vaccination on pre-donation platelet counts of plateletpheresis donors.
Tomar A; Biswas AK; Pawar A; Dimri U; Kumar D; Baranwal AK
Hematol Transfus Cell Ther; 2023; 45(4):456-460. PubMed ID: 36273983
[TBL] [Abstract][Full Text] [Related]
36. Repeat plateletpheresis: the effects on the donor and the yield.
Rock G; Tittley P; Sternbach M; Buskard N; Schroeder M
Vox Sang; 1992; 63(2):102-6. PubMed ID: 1441301
[TBL] [Abstract][Full Text] [Related]
37. 'Ironing out the risk': Assessing the effect of plateletpheresis donation frequency on iron stores in South-Asian male donors.
Madkaiker D; Hiregoudar SS; Chavan P; Ojha S; Mendes J; Shastry S
Vox Sang; 2023 Nov; 118(11):921-929. PubMed ID: 37772675
[TBL] [Abstract][Full Text] [Related]
38. A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.
Arora D; Garg K; Kaushik A; Sharma R; Rawat DS; Mandal AK
J Clin Diagn Res; 2016 Nov; 10(11):EC22-EC24. PubMed ID: 28050376
[TBL] [Abstract][Full Text] [Related]
39. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
[TBL] [Abstract][Full Text] [Related]
40. Assessment of serum iron stores in regular plateletpheresis donors.
Chinigi Sab P; Kaur G; Kaur P; Tahlan A; Bedi RK; Mittal K; Sood T
Transfus Apher Sci; 2022 Feb; 61(1):103291. PubMed ID: 34649790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
